Kristin: According to the Project on Emerging Nanotechnologies Chief Scientist Andrew Maynard, if the benefits of nanotechnology are unclear and consumers and other stakeholders are unsure of the risks, nanotechnology will be a hard sell. Dr Maynard published a document on research strategies for reducing nanotechnology risks in July 2006 and recently presented to the President’s Council of Advisors on Science and Technology (PCAST). I agree risk is a valid concern for consumers that may affect their decisions to buy nanotechnology products. However, if nanotechnology is to be the major selling point in a product, then I also think general understanding of nanotechnolgies needs to be considered in addition to articulating detailed risks and benefits. After all, the Project has also indentified nearly 500 everyday products that use nanotechnology and little public knowledge.